seed
Stage
1
Investors
About
Aquila Bioscience develops a proprietary Pathogen Capture Technology biomimetic platform that captures and neutralises viruses, bacteria, and fungi, enabling chemical-free pathogen control products such as decontamination devices and sprays.
Explore Aquila Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.